After finishing at $38.20 in the prior trading day, Twist Bioscience Corp (NASDAQ: TWST) closed at $40.59, up 6.26%. In other words, the price has increased by $+2.39 from its previous closing price. On the day, 832351 shares were traded. TWST stock price reached its highest trading level at $40.68 during the session, while it also had its lowest trading level at $37.67.
Ratios:
Our goal is to gain a better understanding of TWST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.51 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 17, 2024, Upgraded its rating to Buy and sets its target price to $45 from $25 previously.
On September 27, 2023, Berenberg started tracking the stock assigning a Buy rating and target price of $27.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $33.Scotiabank initiated its Sector Outperform rating on January 05, 2023, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 08 when CHESS ROBERT sold 4,110 shares for $34.98 per share. The transaction valued at 143,784 led to the insider holds 64,169 shares of the business.
Cho Dennis bought 10,000 shares of TWST for $132,000 on May 10. The insider now owns 29,297 shares after completing the transaction at $13.20 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TWST now has a Market Capitalization of 2.21B and an Enterprise Value of 1.99B. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.95 while its Price-to-Book (P/B) ratio in mrq is 3.97. Its current Enterprise Value per Revenue stands at 7.58 whereas that against EBITDA is -11.54.
Stock Price History:
Over the past 52 weeks, TWST has reached a high of $43.21, while it has fallen to a 52-week low of $11.46. The 50-Day Moving Average of the stock is 35.79, while the 200-Day Moving Average is calculated to be 23.82.
Shares Statistics:
The stock has traded on average 1.24M shares per day over the past 3-months and 1.09M shares per day over the last 10 days, according to various share statistics. A total of 57.56M shares are outstanding, with a floating share count of 55.29M. Insiders hold about 4.37% of the company’s shares, while institutions hold 109.09% stake in the company. Shares short for TWST as of Jan 31, 2024 were 12.33M with a Short Ratio of 9.91, compared to 11.62M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 21.32% and a Short% of Float of 27.95%.
Earnings Estimates
Its stock is currently analyzed by 9 different market analysts. On average, analysts expect EPS of -$0.81 for the current quarter, with a high estimate of -$0.75 and a low estimate of -$0.86, while EPS last year was -$1.04. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.69 and low estimates of -$0.84.
Analysts are recommending an EPS of between -$2.84 and -$3.24 for the fiscal current year, implying an average EPS of -$3.08. EPS for the following year is -$2.7, with 9 analysts recommending between -$1.97 and -$3.29.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $299.96M, while the lowest revenue estimate was $290.5M, resulting in an average revenue estimate of $293.24M. In the same quarter a year ago, actual revenue was $245.11M, up 19.60% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $354.11M in the next fiscal year. The high estimate is $384.87M and the low estimate is $340.4M. The average revenue growth estimate for next year is up 20.80% from the average revenue estimate for this year.
